Detection of inhibitors of phenotypically drug-tolerant Mycobacterium tuberculosis using an in vitro bactericidal screen

Streptomycin-Starved Mycobacterium tuberculosis 18b, a Drug Discovery Tool for Latent Tuberculosis

(2012) Ming Zhang et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

How dormant is Mycobacterium tuberculosis during latency? A study integrating genomics and molecular epidemiology

(2011) Zhenhua Yang et al.   INFECTION GENETICS AND EVOLUTION

Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infection

(2011) Christopher B Ford et al.   NATURE GENETICS

Simple Model for Testing Drugs against Nonreplicating Mycobacterium tuberculosis

(2010) C. Sala et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Synthesis and evaluation of anti-tubercular activity of new dithiocarbamate sugar derivatives

(2010) Yasuhiro Horita et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Growth kinetics of Mycobacterium tuberculosis measured by quantitative resazurin reduction assay: a tool for fitness studies

(2010) Andrea von Groll et al.   BRAZILIAN JOURNAL OF MICROBIOLOGY

Modifying Culture Conditions in Chemical Library Screening Identifies Alternative Inhibitors of Mycobacteria

(2009) C. H. Miller et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Mycolic acid methyltransferase, MmaA4, is necessary for thiacetazone susceptibility inMycobacterium tuberculosis

(2009) Anuradha Alahari et al.   MOLECULAR MICROBIOLOGY

A replication clock for Mycobacterium tuberculosis

(2009) Wendy P Gill et al.   NATURE MEDICINE

Genome Analysis of Multi- and Extensively-Drug-Resistant Tuberculosis from KwaZulu-Natal, South Africa

(2009) Thomas R. Ioerger et al.   PLoS One

Discovery of Novel Proteasome Inhibitors Using a High-Content Cell-Based Screening System

(2009) Irena Lavelin et al.   PLoS One

Tuberculous Granulomas Are Hypoxic in Guinea Pigs, Rabbits, and Nonhuman Primates

(2008) L. E. Via et al.   INFECTION AND IMMUNITY